We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$17.8B
AUM Growth
-$2.39B
Cap. Flow
-$2.67B
Cap. Flow %
-15.05%
Top 10 Hldgs %
50.86%
Holding
81
New
3
Increased
21
Reduced
27
Closed
26

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$613M
2
CI icon
Cigna
CI
+$330M
3
HUM icon
Humana
HUM
+$284M
4
FMC icon
FMC
FMC
+$206M
5
CSC
Computer Sciences
CSC
+$201M

Top Sells

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$481M
2
AGN
Allergan plc
AGN
+$414M
3
TMO icon
Thermo Fisher Scientific
TMO
+$344M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$326M
5
CDNS icon
Cadence Design Systems
CDNS
+$311M

Sector Composition

Rank Sector Weight
1 Healthcare 49.67%
2 Materials 13.6%
3 Industrials 9.34%
4 Communication Services 5.71%
5 Technology 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$47.5B
$1.47B 8.29%
8,250,929
+1,615,539
+24% +$284M
MON
2
DELISTED
Monsanto Co
MON
$1.39B 7.81%
14,078,428
+575,750
+4% +$54.1M
CI icon
3
Cigna
CI
$75.8B
$1.02B 5.76%
6,995,201
+2,399,411
+52% +$330M
HCA icon
4
HCA Healthcare
HCA
$85.5B
$967M 5.45%
14,300,549
+8,787,271
+159% +$613M
TMO icon
5
Thermo Fisher Scientific
TMO
$209B
$842M 4.74%
5,933,331
-2,577,873
-30% -$344M
ABBV icon
6
AbbVie
ABBV
$454B
$802M 4.52%
13,544,815
-2,626,088
-16% -$151M
LH icon
7
Labcorp
LH
$23.9B
$699M 3.94%
6,584,769
+920,984
+16% +$95M
AET
8
DELISTED
Aetna Inc
AET
$620M 3.49%
5,737,233
+173,725
+3% +$18.8M
FLEX icon
9
Flex
FLEX
$46.3B
$618M 3.48%
73,158,783
-26,540,000
-27% -$224M
ELV icon
10
Elevance Health
ELV
$82.4B
$600M 3.38%
4,304,065
+53,664
+1% +$7.39M
THC icon
11
Tenet Healthcare
THC
$20.6B
$542M 3.05%
17,890,230
+1,400,000
+8% +$45.9M
DD icon
12
DuPont de Nemours
DD
$18.6B
$478M 2.69%
3,663,793
+792,626
+28% +$102M
FMC icon
13
FMC
FMC
$1.46B
$465M 2.62%
13,710,925
+6,016,374
+78% +$206M
MCK icon
14
McKesson
MCK
$96.9B
$432M 2.44%
2,192,841
+382,592
+21% +$72.2M
PARA
15
DELISTED
Paramount Global Class B
PARA
$408M 2.3%
8,657,912
-2,175,739
-20% -$102M
MAN icon
16
ManpowerGroup
MAN
$2.3B
$405M 2.28%
4,799,409
-1,239,386
-21% -$108M
TEVA icon
17
Teva Pharmaceuticals
TEVA
$36.7B
$391M 2.2%
5,955,796
+1,767,017
+42% +$109M
WOOF
18
DELISTED
VCA Inc.
WOOF
$348M 1.96%
6,320,549
-1,753,121
-22% -$96.2M
CAR icon
19
Avis
CAR
$5.59B
$341M 1.92%
9,393,116
-40,104
-0.4% -$1.69M
BKD icon
20
Brookdale Senior Living
BKD
$3.51B
$335M 1.89%
18,141,415
+500,000
+3% +$10.8M
HRI icon
21
Herc Holdings
HRI
$5.42B
$330M 1.86%
7,734,483
-679,572
-8% -$34.1M
BKNG icon
22
Booking.com
BKNG
$135B
$321M 1.81%
6,298,200
+1,061,450
+20% +$56.1M
CYH icon
23
Community Health Systems
CYH
$395M
$308M 1.73%
14,028,492
-605,000
-4% -$15.6M
HOUS
24
DELISTED
Anywhere Real Estate
HOUS
$249M 1.4%
6,792,206
+462,500
+7% +$18.3M
EHC icon
25
Encompass Health
EHC
$11.4B
$237M 1.34%
8,571,584
– –
1
2 3 4

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Glenview Capital Management held 81 positions worth $17.8B, down 12% from $20.2B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Glenview Capital Management withdrew a net $2.67B in Q4 2015, closing 26 positions and reducing 27 holdings. Its most notable exit was Endo International plc, an estimated $481M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Materials and Industrials.

Against the trend, Glenview Capital Management opened a new position in Computer Sciences worth $225M.

  • Glenview Capital Management's largest Q4 2015 buy was Computer Sciences: 6,879,290 shares worth $225M.
  • Glenview Capital Management added most to HCA Healthcare in Q4 2015, an estimated $613M increase.
  • Glenview Capital Management's biggest Q4 2015 reduction was Thermo Fisher Scientific, cutting an estimated $344M.
  • Glenview Capital Management fully exited Endo International plc in Q4 2015, selling an estimated $481M.
  • Glenview Capital Management's ten largest holdings make up 51% of its $17.8B portfolio in Q4 2015.
  • Glenview Capital Management opened 3 new positions and closed 26 in Q4 2015.
  • Glenview Capital Management's portfolio value fell 12% quarter-over-quarter to $17.8B.

Based on Glenview Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.